Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Email me when HR 10227 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HR 10227. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The INSULIN Act caps out‑of‑pocket costs for selected insulin products at $35 per 30‑day supply or 25 % of the negotiated price, whichever is lower, for all group and individual health plans beginning in 2028. It also bans most deductibles, high cost‑sharing, and prior‑authorization requirements for those insulins, and funds a national resource center and hotline to help uninsured people find assistance. The goal is to make lifesaving insulin more affordable and improve access for those without coverage.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HR 10227
3 free questions a day, no accountSponsors
- Rep. DeGette, Diana [D-CO-1] (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 10227 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 10227 freeOr ask your AI assistant about HR 10227 directly:
Add to Claude, ChatGPT or Cursor